These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II. Lal RB, Rudolph DL, Coligan JE, Brodine SK, Roberts CR. Blood; 1992 Jul 15; 80(2):544-50. PubMed ID: 1627806 [Abstract] [Full Text] [Related]
3. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB. Am J Trop Med Hyg; 1997 Aug 15; 57(2):142-8. PubMed ID: 9288805 [Abstract] [Full Text] [Related]
4. Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors. Anderson DW, Epstein JS, Lee TH, Lairmore MD, Saxinger C, Kalyanaraman VS, Slamon D, Parks W, Poiesz BJ, Pierik LT. Blood; 1989 Nov 15; 74(7):2585-91. PubMed ID: 2804381 [Abstract] [Full Text] [Related]
5. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. Mangano AM, Remesar M, del Pozo A, Sen L. J Med Virol; 2004 Oct 15; 74(2):323-7. PubMed ID: 15332282 [Abstract] [Full Text] [Related]
6. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections. Lal RB, Brodine S, Kazura J, Mbidde-Katonga E, Yanagihara R, Roberts C. J Clin Microbiol; 1992 Feb 15; 30(2):296-9. PubMed ID: 1347047 [Abstract] [Full Text] [Related]
7. Confirmatory tests for human T-cell leukemia virus type 1 (HTLV-1): western blot compared with RIPA on African sera. Verdier M, Leonard G, Sangare A, Prince-David M, Bonis J, Barin F, Denis F. J Virol Methods; 1990 Dec 15; 30(3):283-9. PubMed ID: 2086599 [Abstract] [Full Text] [Related]
12. Long-term serological follow-up of blood donors with an HTLV-indeterminate western blot: antibody profile of seroconverters and individuals with false reactions. Martins ML, Santos AC, Namen-Lopes MS, Barbosa-Stancioli EF, Utsch DG, Carneiro-Proietti AB. J Med Virol; 2010 Oct 15; 82(10):1746-53. PubMed ID: 20827773 [Abstract] [Full Text] [Related]
13. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group. Kleinman SH, Kaplan JE, Khabbaz RF, Calabro MA, Thomson R, Busch M. J Clin Microbiol; 1994 Mar 15; 32(3):603-7. PubMed ID: 8195365 [Abstract] [Full Text] [Related]
14. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users. Aboulafia DM, Feigal E, Vranzian K, Bennett C, Blattner W, Moss A, Slamon D. AIDS Res Hum Retroviruses; 1993 Oct 15; 9(10):1043-50. PubMed ID: 7904169 [Abstract] [Full Text] [Related]
16. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Busch MP, Switzer WM, Murphy EL, Thomson R, Heneine W. Transfusion; 2000 Apr 15; 40(4):443-9. PubMed ID: 10773057 [Abstract] [Full Text] [Related]
17. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Busch MP, Laycock M, Kleinman SH, Wages JW, Calabro M, Kaplan JE, Khabbaz RF, Hollingsworth CG. Blood; 1994 Feb 15; 83(4):1143-8. PubMed ID: 8111054 [Abstract] [Full Text] [Related]